Abstract:Objectives A sham-controlled, randomized prospective trial in men with ED was performed using an electrohydraulic shockwave device (Softwave/Urogold, TRT). Methods In this single-blind study performed in men with ED, participants were randomized 2:1 to active low intensity shockwave therapy (LiSWT) (4 Hz, 0.12 mJ/mm 2 ) or sham. Arm 1 consisted of 3 treatments of 5000 shocks every 3 weeks. Arm 2 consisted of 5000, 3000, 3000 shocks during weeks 1, 2, 3, respectively, followed by an identical cycle of treatment 3 weeks later. Doppler ultrasound/grayscale was performed at weeks 20 and 32. Participants completing sham treatment crossed over to LiSWT. Post-treatment end diastolic velocity (EDV) and peak systolic velocity (PSV) were measured, and visual grading scores used to assess hypoechoic regions in the corpora cavernosa. Data were analyzed by 2-way repeated measures ANOVA with Geisser-Greenhouse correction. Pairwise comparisons were performed to baseline using Dunnett's multiple comparison test. Missing data were imputed by "last observation carried forward". Results 36 participants (22 active, 14 sham) were randomized. Sham treatments showed no significant changes. Visual grading scores in the proximal region were consistently higher with active LiSWT vs sham (Arm 1 = 88.9% vs. 11.1%; Arm 2 = 40.0% vs. 20.0%, respectively), statistically significant in Arm 1 at weeks 20 (p=0.005) and 32 (p=0.001). Sham participants also had improved grayscale ratings after LiSWT (Arm 1 = 33.3% vs. 11.1%; Arm 2 = 40.0% vs. 20.0%). After LiSWT, greater numbers of patients had higher PSV, lower EDV, or no worsening relative to baseline. Decrease in EDV was statistically significant in active treatment Arm 2 at Week 32 (p=0.003). Adverse events were transient. Conclusions Statistically significant changes from baseline between sham and active treatments in primary outcome measures with no adverse events support safety and efficacy of LiSWT for treating ED. Conflicts of Interest No conflicts of interest.

(181) Low Intensity Shockwave Therapy For Erectile Dysfunction: A Sham-Controlled Randomized Trial